The objective of this Fund is to achieve income and capital growth.
Name | % Net Assets |
---|---|
BP | 8.4% |
HSBC | 7.9% |
BP | 7.6% |
GlaxoSmithKline | 5.2% |
GlaxoSmithKline | 5.0% |
Astrazeneca | 3.5% |
BHP Billiton | 3.1% |
Rio Tinto | 3.1% |
Standard Chartered | 2.9% |
BG Group | 2.7% |
Key | % Net Assets |
---|---|
BP | 8.4% |
HSBC | 7.9% |
BP | 7.6% |
GlaxoSmithKline | 5.2% |
Other | 70.9% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 31/10/1995 |
---|---|
Fund Manager | Batterymarch Financial Management |
TER | 1.80 (31-Aug-2010) |
Minimum Investment | |
---|---|
Initial | 3000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.05 |
You are here: research